Ramucirumab in combination with Paclitaxel as second-line treatment for adult patients with advanced gastric or gastro-oesophageal junction Adenocarcinoma
Country | Agency | Status | Link | Details on adaptation process | Contact information |
|---|---|---|---|---|---|
Austria | LBI-HTA | Published September 2015 | Link to report
In English | Adapting: systematic extraction of relevant HTA information from an existing joint assessment. | Anna Nachtnebel
anna.nachtnebel@hta.lbg.ac.at |
Belgium | KCE | Published October 2015 | Link to report
In English | Preparation of a 2 pages news-item. | Patrice Chalon
patrice.chalon@kce.fgov.be
|
Belgium | RIZIV | Used in cross-checking evidence. | Francis Arickx
francis.arickx@riziv.fgov.be | ||
Belgium | KCE | Link to summary | Analysis of scientific context and its relevance, “KCE has read for you”. | Patrice Chalon
patrice.chalon@kce.fgov.be | |
Finland | FIMEA | Published 2015 | Link to report
Abstract in English Report in Finnish | Adapting: systematic extraction of relevant HTA information from an existing joint assessment. | Ulla Harkonen
ulla.harkonen@fimea.fi
or
vesa.kiviniemi@fimea.fi |
Hungary | NIPN | Used to validate technology developer submission of evidence | NIPN (HUNHTAWP7@ogyei.gov.hu) | ||
Netherlands | ZIN | 2015 | Link to report | Used in direct decision-making | Hedi Schelleman, Implementation Officer
hschelleman@zinl.nl |
Slovakia | MoH SK | Used in direct decision-making. | Tomas Tesar
tomas.tesar@union.sk |
